HK · Other

CH GRAND PHARM & HEALTHCARE HLDGS (512)

Other

CH GRAND PHARM & HEALTHCARE HLDGS (512) is listed on HK in the Other sector. As of 2026-05-21, reported P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Key metrics for 512

P/E ratio
18.00
Gross profit (TTM)
$0
Net margin
0.0%

CH GRAND PHARM & HEALTHCARE HLDGS (512) — FAQ

What is 512's P/E ratio?

The price-to-earnings (P/E) ratio for CH GRAND PHARM & HEALTHCARE HLDGS (512) is 18.00 (data as of 2026-05-21).

Does CH GRAND PHARM & HEALTHCARE HLDGS pay a dividend?

Dividend yield is not available in the current snapshot for CH GRAND PHARM & HEALTHCARE HLDGS (512). Check the MyAverix Finance app for the latest dividend data.

What sector is CH GRAND PHARM & HEALTHCARE HLDGS in?

CH GRAND PHARM & HEALTHCARE HLDGS (512) is classified in the Other sector.

What exchange is 512 listed on?

512 is listed on HK.

What is CH GRAND PHARM & HEALTHCARE HLDGS's net margin?

CH GRAND PHARM & HEALTHCARE HLDGS (512) reports a net margin of 0.0% (data as of 2026-05-21).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Other companies

App Store Google Play